BUGLIONE DI MONALE E BASTIA, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 14.706
AS - Asia 5.912
EU - Europa 5.334
SA - Sud America 1.069
Continente sconosciuto - Info sul continente non disponibili 432
AF - Africa 148
OC - Oceania 21
Totale 27.622
Nazione #
US - Stati Uniti d'America 14.355
SG - Singapore 2.001
CN - Cina 1.967
IT - Italia 1.048
UA - Ucraina 1.009
BR - Brasile 893
DE - Germania 821
HK - Hong Kong 678
PL - Polonia 617
FI - Finlandia 377
FR - Francia 360
VN - Vietnam 345
GB - Regno Unito 324
RU - Federazione Russa 262
TR - Turchia 239
IE - Irlanda 192
BD - Bangladesh 179
IN - India 165
CA - Canada 152
MX - Messico 69
AR - Argentina 56
ZA - Sudafrica 55
ID - Indonesia 49
IQ - Iraq 49
NL - Olanda 46
SE - Svezia 46
CZ - Repubblica Ceca 43
ES - Italia 37
JP - Giappone 37
EC - Ecuador 36
CO - Colombia 30
LT - Lituania 29
PK - Pakistan 27
UZ - Uzbekistan 24
AT - Austria 22
SA - Arabia Saudita 22
VE - Venezuela 22
BE - Belgio 21
NG - Nigeria 19
MA - Marocco 18
TT - Trinidad e Tobago 18
AU - Australia 17
CR - Costa Rica 16
JM - Giamaica 16
EU - Europa 14
SV - El Salvador 13
TN - Tunisia 13
GR - Grecia 12
IL - Israele 12
MY - Malesia 11
PR - Porto Rico 11
PY - Paraguay 11
EG - Egitto 10
HN - Honduras 10
IR - Iran 10
PA - Panama 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
CL - Cile 9
GT - Guatemala 9
JO - Giordania 9
NI - Nicaragua 9
PH - Filippine 9
BY - Bielorussia 8
NP - Nepal 8
OM - Oman 8
CH - Svizzera 7
DZ - Algeria 7
KE - Kenya 7
KG - Kirghizistan 7
SN - Senegal 7
AZ - Azerbaigian 6
HU - Ungheria 6
KZ - Kazakistan 6
TH - Thailandia 6
CW - ???statistics.table.value.countryCode.CW??? 5
PT - Portogallo 5
TW - Taiwan 5
BG - Bulgaria 4
BO - Bolivia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GP - Guadalupe 4
LA - Repubblica Popolare Democratica del Laos 4
BZ - Belize 3
KH - Cambogia 3
KR - Corea 3
KW - Kuwait 3
LB - Libano 3
LV - Lettonia 3
MU - Mauritius 3
NO - Norvegia 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AM - Armenia 2
AW - Aruba 2
BS - Bahamas 2
Totale 27.175
Città #
Ashburn 1.533
Fairfield 1.305
Woodbridge 1.086
Singapore 1.083
Jacksonville 732
San Jose 732
Houston 703
Hong Kong 673
Warsaw 604
Seattle 577
Cambridge 540
Chandler 536
Ann Arbor 495
Wilmington 475
Beijing 434
Council Bluffs 388
The Dalles 385
New York 372
Princeton 338
Los Angeles 261
Helsinki 220
Nanjing 212
Dublin 191
Dearborn 178
Istanbul 177
Lauterbourg 175
Dallas 166
Munich 146
Milan 122
Brescia 121
Columbus 117
São Paulo 103
Buffalo 102
Ho Chi Minh City 98
Santa Clara 95
Shanghai 95
San Francisco 94
Nanchang 91
Des Moines 89
Moscow 84
San Diego 72
Chicago 67
Changsha 64
Orem 58
Hanoi 53
Dong Ket 52
Shenyang 51
Jinan 50
Washington 50
Hebei 49
London 49
Tianjin 48
Phoenix 47
Turku 47
North Bergen 46
Redondo Beach 46
Boardman 45
Montreal 43
Denver 39
Brooklyn 37
Jiaxing 37
Toronto 37
Chennai 34
Kunming 34
Nuremberg 34
Rome 32
Tokyo 32
Hangzhou 31
Johannesburg 31
Atlanta 29
Frankfurt am Main 29
Jakarta 28
Poplar 28
Rio de Janeiro 28
Naples 27
Brno 26
Mexico City 26
Lancaster 25
Zhengzhou 25
Manchester 24
Brasília 23
Tashkent 22
Brussels 21
Newark 21
Ningbo 21
Boston 20
Amsterdam 19
Abuja 18
Dhaka 18
Kocaeli 18
Stockholm 18
Vilnius 18
Charlotte 17
Da Nang 17
Guangzhou 17
Ceto 16
Curitiba 16
Haikou 16
Mumbai 16
Quito 16
Totale 17.906
Nome #
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 290
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 282
Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma 278
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 272
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 268
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 242
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 237
Pros-IT CNR: an Italian prostate cancer monitoring project 230
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 227
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 223
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 221
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 218
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 216
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 207
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 206
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 202
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 200
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 198
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 198
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 196
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 195
Radiotherapy in patients with HIV: current issues and review of the literature 195
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 195
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 192
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 191
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 187
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 186
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 186
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 186
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 184
From Molecular to Clinical Radiation Biology of Glioblastoma 184
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 182
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 182
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 182
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 181
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 180
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 179
Role of external beam radiotherapy in the treatment of relapsing meningioma 179
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 178
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 178
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 178
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 178
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 175
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 175
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 174
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 174
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 174
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 174
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 173
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 172
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 172
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 171
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 170
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 169
Treatment of anal canal cancer: a retrospective study about long term results in 82 patients. 169
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 169
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 168
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 168
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 167
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 167
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 166
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 166
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 164
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 163
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 163
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 163
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 163
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 159
Letter to “Medial lingual lymph node metastasis in carcinoma of the tongue” 159
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 158
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 157
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 156
Benign tumors of parotid gland treated with radiotherapy: a retrospective study 155
A case report on how facing it problems: improving the reliability of a dicom router system through an affordable backup solution. 155
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 154
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 153
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 153
Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection? 152
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 151
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 151
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 151
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 148
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 148
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 148
Cetuximab and Radiation Therapy in Head and Neck Cancer 148
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 148
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 147
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 146
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 143
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 143
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 143
Circulating tumor cells (CTCS): from theory to practice in radio(chemo) therapy 142
Information Retrieval in Medicine: an Extensive Experimental Study 141
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 141
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 140
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 140
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 140
Radical radiotherapy of bladder cancer retrospective analysis of a series of 459 patients treated in an Italian Institution 139
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 138
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 138
Totale 17.783
Categoria #
all - tutte 132.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.010 0 0 0 58 16 75 54 113 75 161 86 372
2022/20231.362 188 88 47 103 126 339 6 138 214 17 53 43
2023/20241.813 87 32 192 94 97 413 64 80 350 53 79 272
2024/20253.375 31 41 29 491 333 300 285 139 317 286 725 398
2025/20267.197 680 915 493 936 762 487 1.048 246 473 603 369 185
2026/20272.289 272 335 590 1.092 0 0 0 0 0 0 0 0
Totale 27.622